BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20561037)

  • 1. Frontotemporal dementia and parkinsonism linked to chromosome 17--the first Polish family.
    Narożańska E; Jasińska-Myga B; Sitek EJ; Robowski P; Brockhuis B; Lass P; Dubaniewicz M; Wieczorek D; Baker M; Rademakers R; Wszolek ZK; Sławek J
    Eur J Neurol; 2011 Mar; 18(3):535-7. PubMed ID: 20561037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
    Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
    Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAPT mutation associated with frontotemporal dementia and parkinsonism (FTDP-17).
    Haussmann R; Wysocki M; Brandt MD; Hermann A; Donix M
    Int Psychogeriatr; 2017 May; 29(5):869-871. PubMed ID: 27905268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation.
    Morino H; Kurashige T; Matsuda Y; Ono M; Sahara N; Miyasaka T; Soeda Y; Shimada H; Yamazaki Y; Takahashi T; Izumi Y; Ito H; Maruyama H; Higuchi M; Arihiro K; Suhara T; Takashima A; Kawakami H
    Mov Disord Clin Pract; 2024 Jun; 11(6):720-727. PubMed ID: 38605589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agraphia in patients with frontotemporal dementia and parkinsonism linked to chromosome 17 with P301L MAPT mutation: dysexecutive, aphasic, apraxic or spatial phenomenon?
    Sitek EJ; Narozanska E; Barczak A; Jasinska-Myga B; Harciarek M; Chodakowska-Zebrowska M; Kubiak M; Wieczorek D; Konieczna S; Rademakers R; Baker M; Berdynski M; Brockhuis B; Barcikowska M; Zekanowski C; Heilman KM; Wszolek ZK; Slawek J
    Neurocase; 2014; 20(1):69-86. PubMed ID: 23121543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.
    Gatto EM; Allegri RF; Da Prat G; Chrem Mendez P; Hanna DS; Dorschner MO; Surace EI; Zabetian CP; Mata IF
    Neurobiol Aging; 2017 May; 53():195.e11-195.e17. PubMed ID: 28268100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical, pathological, and genetic characteristics of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in the MAPT and PGRN].
    Tsuboi Y
    Brain Nerve; 2009 Nov; 61(11):1285-91. PubMed ID: 19938685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset.
    Wu L; Liu J; Feng X; Dong J; Qin W; Liu Y; Wang J; Lu J; Chen K; Wang Y; Jia J
    J Alzheimers Dis; 2018; 61(2):613-618. PubMed ID: 29226866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Genetic Study of the First Japanese FTDP-17 Patient with a Mutation of +3 in Intron 10 in the MAPT Gene.
    Nan H; Takaki R; Shimozono K; Ichinose Y; Koh K; Takiyama Y
    Intern Med; 2019 Aug; 58(16):2397-2400. PubMed ID: 30996196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closing the tau loop: the missing tau mutation.
    McCarthy A; Lonergan R; Olszewska DA; O'Dowd S; Cummins G; Magennis B; Fallon EM; Pender N; Huey ED; Cosentino S; O'Rourke K; Kelly BD; O'Connell M; Delon I; Farrell M; Spillantini MG; Rowland LP; Fahn S; Craig P; Hutton M; Lynch T
    Brain; 2015 Oct; 138(Pt 10):3100-9. PubMed ID: 26297556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting genotypes of the tau gene in two phenotypically distinct patients with P301L mutation of frontotemporal dementia and parkinsonism linked to chromosome 17.
    Kobayashi T; Mori H; Okuma Y; Dickson DW; Cookson N; Tsuboi Y; Motoi Y; Tanaka R; Miyashita N; Anno M; Narabayashi H; Mizuno Y
    J Neurol; 2002 Jun; 249(6):669-75. PubMed ID: 12111297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
    Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
    Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features.
    Ikeda A; Shimada H; Nishioka K; Takanashi M; Hayashida A; Li Y; Yoshino H; Funayama M; Ueno Y; Hatano T; Sahara N; Suhara T; Higuchi M; Hattori N
    Mov Disord; 2019 Apr; 34(4):568-574. PubMed ID: 30773680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia.
    Momeni P; Wickremaratchi MM; Bell J; Arnold R; Beer R; Hardy J; Revesz T; Neal JW; Morris HR
    Clin Neurol Neurosurg; 2010 Dec; 112(10):917-20. PubMed ID: 20708332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous MAPT R406W mutation causing FTDP phenotype: A unique instance of a unique mutation.
    Behnam M; Ghorbani F; Shin JH; Kim DS; Jang H; Nouri N; Sedghi M; Salehi M; Ansari B; Basiri K
    Gene; 2015 Oct; 570(1):150-2. PubMed ID: 26086902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation.
    Boeve BF; Tremont-Lukats IW; Waclawik AJ; Murrell JR; Hermann B; Jack CR; Shiung MM; Smith GE; Nair AR; Lindor N; Koppikar V; Ghetti B
    Brain; 2005 Apr; 128(Pt 4):752-72. PubMed ID: 15615814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontotemporal dementia with Parkinsonism linked to chromosome-17 mutations enhance tau oligomer formation.
    Maeda S; Sato Y; Takashima A
    Neurobiol Aging; 2018 Sep; 69():26-32. PubMed ID: 29852407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTDP-17 with Pick body-like inclusions associated with a novel tau mutation, p.E372G.
    Tacik P; DeTure MA; Carlomagno Y; Lin WL; Murray ME; Baker MC; Josephs KA; Boeve BF; Wszolek ZK; Graff-Radford NR; Parisi JE; Petrucelli L; Rademakers R; Isaacson RS; Heilman KM; Petersen RC; Dickson DW; Kouri N
    Brain Pathol; 2017 Sep; 27(5):612-626. PubMed ID: 27529406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between a MAPT variant causing frontotemporal dementia and mutant APP affects axonal transport.
    Adalbert R; Milde S; Durrant C; Ando K; Stygelbout V; Yilmaz Z; Gould S; Brion JP; Coleman MP
    Neurobiol Aging; 2018 Aug; 68():68-75. PubMed ID: 29729423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial semantic dementia with P301L mutation in the Tau gene.
    Ishizuka T; Nakamura M; Ichiba M; Sano A
    Dement Geriatr Cogn Disord; 2011; 31(5):334-40. PubMed ID: 21555888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.